Temsirolimus (Compound)

Synonyms:Temsirolimus, Torisel, CCI-779, 162635-04-3, 624KN6GM2T, CHEMBL1201182, DTXSID2040945, Cci 779, NCGC00167518-01, Rapamycin 42-(2,2-bis(hydroxymethyl)propionate), Rapamycin 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate], Rapamycin, 42-(3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate), CHEBI:79699, Temserolimus, NSC-683864, MFCD00934421, Temsirolimus (CCI-779, NSC 683864), Temsirolimus [USAN], Temsirolimus - Torisel, TEMSIROLIMUS [MI], TEMSIROLIMUS [INN], TEMSIROLIMUS [JAN], TEMSIROLIMUS [VANDF], UNII-624KN6GM2T, SCHEMBL18792, TEMSIROLIMUS [MART.], 42-(3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate)rapamycin, TEMSIROLIMUS [WHO-DD], WAY-CCI 779, GTPL5892, TEMSIROLIMUS [EMA EPAR], DTXCID0020945, HSDB 7931, Temsirolimus, >=98% (HPLC), TEMSIROLIMUS [ORANGE BOOK], 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]-rapamycin, Temsirolimus [USAN:INN:BAN:JAN], Tox21_112515, BDBM50343413, s1044, AKOS025142069, AM84554, CCG-264790, CS-0129, NCGC00167518-02, NCGC00167518-05, NCGC00167518-09, HY-50910, CAS-162635-04-3, T3574, AB01274736-01, AB01274736_02, SR-01000898799, J-009958, Q7699074, SR-01000898799-3, BRD-K08177763-001-02-6, (1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,30S,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate, A4I

Pubchem:PUBCHEM:6440033

Id:25266fbd-f31b-5039-a2eb-db851ef4e23c

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Temsirolimus's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Temsirolimus.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Temsirolimus.

Results found

Linked to

	Label	Description
	BRD-K08177763-001-02-6 Substance (Entity type)	A Substance
	Ascomycin in similarity relationship with Temsirolimus Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	GSK269962A in similarity relationship with Temsirolimus Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Temsirolimus negatively regulates PSAT1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Temsirolimus negatively regulates NSDHL Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Temsirolimus positively regulates AMIGO2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Temsirolimus positively regulates IFI27 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Temsirolimus positively regulates MYC Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Temsirolimus negatively regulates DHCR7 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Temsirolimus positively regulates TXNIP Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS